Our API co-development model is built on strategic collaboration, combining scientific expertise, regulatory capabilities, and commercial insight to develop high-value APIs. Together, we reduce development risks, optimize investment, and accelerate commercialization through shared responsibility and long-term partnerships.
Working across the entire API lifecycle, we provide the expertise, infrastructure, and market knowledge needed to transform promising molecules into commercially successful products.
Years Pharmaceutical Experience
complex API Development
Strategic Partnerships
Global regulatory expertise
Our co-development approach supports the complete journey from molecule evaluation and process development through scale-up, technology transfer, and commercial manufacturing readiness, ensuring a seamless path from innovation to market.
Evaluate molecule potential, commercial opportunities, and strategic alignment to establish a strong foundation for API co-development.
Assess technical feasibility, intellectual property, regulatory requirements, and project risks to support informed development decisions.
Define a structured development roadmap with clear milestones, timelines, resource allocation, and project responsibilities.
Collaborate on API process development, analytical method development, process optimization, and technical execution.
Scale validated processes for commercial manufacturing through efficient technology transfer and process validation.
Develop regulatory documentation and submission strategies to support compliance across target markets.
Establish robust manufacturing processes and supply chain alignment to support successful product launch and long-term commercialization.
Enable seamless transfer of process knowledge, analytical methods, and manufacturing expertise to ensure efficient scale-up and successful commercialization.
Provide ongoing technical, regulatory, and manufacturing support throughout the product lifecycle to ensure continuous improvement and long-term product success.
Our API co-development partnership models are designed to align scientific expertise, shared investment, and commercial objectives. Whether supporting early-stage development or long-term product success, each model provides the flexibility to accelerate innovation while reducing development risk.
Collaborate on API development through shared scientific expertise, technical resources, and project execution.
Share development costs, technical risks, and project milestones through a collaborative partnership model.
Co-develop proprietary technologies, innovative processes, and complex APIs for long-term competitive advantage.
Streamline development, regulatory strategy, and manufacturing planning to reduce timelines and support faster commercialization.
OrdoActive supports pharmaceutical innovators with flexible API co-development solutions backed by integrated scientific capabilities, regulatory expertise, and scalable manufacturing. Our partnership-driven approach enables faster development, optimized investment, and long-term commercial success.
